This study aims to determine the status of HER2/neu in breast carcinoma tissue specimens by immunohisto-chemical and FISH techniques and the association of clinicopathological parameters with ER, PR, HER-2/neu, and Ki-67. This evidence concerns the gene MKI67 and breast carcinoma.